Newsroom

BOSTON--(BUSINESS WIRE)--Hometap, the Boston-based financial technology company pioneering home equity financing solutions, today announced two senior appointments to its executive leadership team, welcoming Jesse Silverman as General Counsel and Josh Berg as Chief Product Officer. Silverman will report to Hometap Chief Executive Officer, Jeffrey Glass, and Berg will report to Hometap President and Chief Operating Officer, Sarah Dekin. These strategic hires reflect Hometap’s continued investmen...

PARIS--(BUSINESS WIRE)--Groupe Pierre & Vacances-Center parcs : Nombre d'actions et de droits de vote au 31 janvier 2026...

PARIS--(BUSINESS WIRE)--Regulatory News: Pierre & Vacances-Center Parcs (Paris:VAC): Date Number of shares(*) Number of theoretical voting rights Number of actual voting rights (exercisable at General Meetings) (**) 31 January 2026 461 988 465 461 988 465 461 860 183 (*) Ordinary shares only, i.e. excluding 1,130 preferred shares not admitted to trading. (**) Excluding treasury shares, which are deprived of voting rights (the 1,130 preferred shares not carrying voting rights and are not bei...

OAK RIDGE, Tenn.--(BUSINESS WIRE)--The U.S. Department of Energy (DOE) National Supplemental Screening Program (NSSP), managed by ORAU, is celebrating 20 years of continued service and encourages those eligible to participate in the program. The NSSP, part of the DOE Former Worker Medical Screening Program (FWP), offers medical screening exams at no cost to DOE former federal, contractor and subcontractor workers who may be at risk for occupational diseases. To date, more than 25,000 individual...

ELMORE CITY, Okla.--(BUSINESS WIRE)--Old Glory Bank, serving customers in all 50 states with its pro-America, FDIC-insured, online banking platform, today announced continued momentum in its small and medium business banking growth, reporting a 10% increase in new business deposit accounts in January 2026. The Bank opened over 435 new business accounts in January 2026, bringing the total number of small and medium business accounts to more than 4,500. This milestone reflects accelerating demand...

SEATTLE--(BUSINESS WIRE)--Snohomish Co. has been sued for retaliation after a former officer reported harassment at Denney Juvenile Justice Center, according to Hagens Berman....

DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc gab heute bekannt, dass Blue Cross Blue Shield of North Dakota eine positive Kostenübernahme für die ReActiv8 Restorative NeurostimulationTM-Therapie des Unternehmens zur Behandlung von hartnäckigen chronischen Rückenschmerzen beschlossen hat. Die Richtlinie trat im Januar 2026 in Kraft und legt fest, dass ReActiv8 die einzige Therapie ist, die von der Richtlinie als medizinisch notwendig angesehen wird, wenn die Bedingungen für die Kostenü...

DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc heeft vandaag bekendgemaakt dat Blue Cross Blue Shield of North Dakota een gunstige dekking heeft ingesteld voor de ReActiv8 Restorative NeurostimulationTM-therapie van het bedrijf voor de behandeling van hardnekkige chronische lage rugpijn. Het beleid is in januari 2026 van kracht geworden en specificeert dat ReActiv8 de enige therapie is die door het beleid als medisch noodzakelijk wordt beschouwd wanneer aan de voorwaarden voor dekking i...

DUBLINO--(BUSINESS WIRE)--Mainstay Medical Holdings plc oggi ha annunciato che Blue Cross Blue Shield del Nord Dakota ha stabilito una copertura vantaggiosa per la terapia ReActiv8 Restorative NeurostimulationTM per il trattamento della lombalgia cronica intrattabile. La politica è entrata in vigore nel gennaio 2026 e specifica che ReActiv8 è l'unica terapia considerata necessaria dal punto di vista medico quando vengono soddisfatti i requisiti per la copertura. “Siamo lieti che un altro membro...

DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc a annoncé aujourd’hui que Blue Cross Blue Shield of North Dakota a établi une couverture favorable pour la thérapie ReActiv8 Restorative NeurostimulationTM de la société pour le traitement des douleurs lombaires chroniques réfractaires. Cette politique est entrée en vigueur en janvier 2026 et précise que ReActiv8 est la seule thérapie considérée comme médicalement nécessaire par la police lorsque les conditions de couverture sont remplies....